North American Apheresis Disposables Research Report
- Report Code: AP 1003
- Publish Date: Upcoming
The North American Apheresis disposables market is mainly driven by increasing prevalence of blood disorders such as bleeding problem and platelet disorder. Some of the other factors for pushing the market growth are growing prevalence of chronic diseases such as cancer or autoimmune diseases, supply of platelets owing to an increasing number of platelet donors, improvement in healthcare infrastructure and facilities and demand for plasma by biopharmaceutical companies.
The report “North American Apheresis disposables Market forecast, 2008-2018” analyzes the market of disposables by 3 main segments such as by applications, procedures, and technologies. On the basis of applications, North American apheresis disposables market is segmented as renal diseases, hematology, and neurology. Based on procedures, the market is divided into Plasmapheresis, LDL-apheresis, Plateletpheresis, Leukapheresis, Photophereis, and Erythrocytapheresis. While, depending upon technologies, the market is classified as; membrane filtration, and centrifugation.
All the markets have been witnessing the maximum growth because of increasing prevalence of blood disorders such as bleeding problem and platelet disorder increase in patient pool.
Geographically, the market is mainly segmented into U.S., Canada, and Mexico.
The report also provides an extensive competitive landscaping of companies operating in this market. The main companies operating in apheresis device market and extensively covered in this report are Asahi Kasei Kuraray Medical Co., Ltd., Terumo BCT Inc., Haemonetics Corp., Kawasumi Laboratories Inc., Hemacare Corporation, Fenwal Inc.
In addition to this, the report also provides insights about the apheresis disposables industry along with issues in the apheresis disposables market, such as refurbishment cuts.
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
Along with the market data, you can also customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Epidemiology Data
- Market share, by type of product and market share by, regions and product.
- Country specific Patient pool of cancer, blood disorders.
- Disease progression (Pattern analysis)
- Distribution channels
Procedure Volume Data
- Number of apheresis procedures
Surgeons/Physicians Perception Analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and Macroeconomic indicators (Number of Hospitals and Orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Apheresis Market The North American Apheresis market was valued at $641.71 million in 2013 and is expected to reach $1062.59 million by 2018 growing at a CAGR of 10.6% from 2013 to 2018. Apheresis market can be segmented by By Procedure: Donor Apheresis and Therapeutic Apheresis (Neurologic Disorders, Blood Disorders (TTP, Leukemia, & Others), Renal Disease , Metabolic Disorders, Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others) By Application: (Plasmapheresis, Plateletpheresis Erythrocytapheresis, Leukoreduction/leukapheresis, Others (photopheresis, lipidpheresis, and Immunoadsoption) By Technology: Centrifugation and Membrane Separation/Filtration By Product type: Devices and Disposables By End-user: Blood banks/Blood collection centers, Hospitals & Hospital attached blood banks and Others The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany),& Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack. |
Upcoming |
|
|
European Apheresis Market The European Apheresis market was valued at $6366.89 million in 2013 and is expected to reach $596.13 million by 2018 growing at a CAGR of 10.2% from 2013 to 2018. Apheresis market can be segmented by By Procedure: Donor Apheresis and Therapeutic Apheresis (Neurologic Disorders, Blood Disorders (TTP, Leukemia, & Others), Renal Disease , Metabolic Disorders, Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others) By Application: (Plasmapheresis, Plateletpheresis Erythrocytapheresis, Leukoreduction/leukapheresis, Others (photopheresis, lipidpheresis, and Immunoadsoption) By Technology: Centrifugation and Membrane Separation/Filtration By Product type: Devices and Disposables By End-user: Blood banks/Blood collection centers, Hospitals & Hospital attached blood banks and Others The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany),& Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack. |
Upcoming |
|
|
Asian Apheresis Market The Asian Apheresis market was valued at $353.79 million in 2013 and is expected to reach $467.59 million by 2018 growing at a CAGR of 13.0% from 2013 to 2018. Apheresis market can be segmented by By Procedure: Donor Apheresis and Therapeutic Apheresis (Neurologic Disorders, Blood Disorders (TTP, Leukemia, & Others), Renal Disease , Metabolic Disorders, Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others) By Application: (Plasmapheresis, Plateletpheresis Erythrocytapheresis, Leukoreduction/leukapheresis, Others (photopheresis, lipidpheresis, and Immunoadsoption) By Technology: Centrifugation and Membrane Separation/Filtration By Product type: Devices and Disposables By End-user: Blood banks/Blood collection centers, Hospitals & Hospital attached blood banks and Others The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany),& Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack. |
Upcoming |
